Dermatitis : contact, atopic, occupational, drug
Letter: Lebrikizumab for Refractory Atopic Dermatitis.
Natalia V Chalupczak, Peter Lio
Published: 202510.1177/17103568251394379
No abstract available for this study.
Natalia V Chalupczak, Peter Lio
No abstract available for this study.